These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 37923879)
41. Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al. Brown KT; Do R; Gönen M; Covey AM; Getrajdman GI; Sofocleous CT; Jarnagin WR; D'Angelica MI; Allen PJ; Erinjeri JP; Brody LA; O'Neill GP; Johnson K; Garcia AR; Beattie CM; Zhao B; Solomon SB; Schwartz LH; DeMatteo RP; Abou-Alfa GK J Clin Oncol; 2017 Jan; 35(2):258-259. PubMed ID: 28056199 [No Abstract] [Full Text] [Related]
42. Authors' reply to Braillon and Bewley, Spiller and colleagues, and Wu. Vaucher J; Chocron Y BMJ; 2019 Sep; 366():l5622. PubMed ID: 31548260 [No Abstract] [Full Text] [Related]
43. Reply to Braillon et al.: Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence? Barrio P; Ortega L; Guardia J; Roncero C; Yuguero L; Gual A Clin Drug Investig; 2018 Apr; 38(4):387-388. PubMed ID: 29480453 [No Abstract] [Full Text] [Related]
44. Reply to "Innovation and off-label use, the French case and more" by Braillon and Lexchin. Borysowski J; Ehni HJ; Górski A Br J Clin Pharmacol; 2019 Oct; 85(10):2448-2449. PubMed ID: 31410871 [No Abstract] [Full Text] [Related]
45. The future of liver transplantation: an interview with Pierre-Alain Clavien. Clavien PA Hepat Oncol; 2020 Jun; 7(2):HEP23. PubMed ID: 32647568 [TBL] [Abstract][Full Text] [Related]
46. Authors' reply to Braillon and Bewley. Ussher M; Coleman T; West R; Aveyard P; Lewis S BMJ; 2015 Jun; 350():h3555. PubMed ID: 26126981 [No Abstract] [Full Text] [Related]
47. Rethinking Low-Risk Drinking Guidelines Through a Psychosocial Availability Lens: A Reply to Nason (2020) and Braillon (2020). Sherk A; Thomas G; Churchill S; Stockwell T J Stud Alcohol Drugs; 2020 Nov; 81(6):830-832. PubMed ID: 33308416 [No Abstract] [Full Text] [Related]
48. Reply to Braillon: Vitamin C to Pregnant Smokers and Infant Airway Function: Missing the Forest for the Trees? McEvoy CT; Tepper RS; Gonzales D; Spindel ER; Morris CD Am J Respir Crit Care Med; 2019 Aug; 200(3):397-398. PubMed ID: 30950629 [No Abstract] [Full Text] [Related]
49. Authors' Reply to Braillon and Martin's Comment on "Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)". Bahri P; Morales DR; Inoubli A; Dogné JM; Straus SMJM Drug Saf; 2021 Sep; 44(9):1011-1013. PubMed ID: 34324172 [No Abstract] [Full Text] [Related]
50. Patentability of time-lapse monitoring has nothing to do with human dignity: A response to Alain Pottage. Beriain IM; Sanz B Reprod Biomed Online; 2018 Oct; 37(4):390-392. PubMed ID: 30241770 [TBL] [Abstract][Full Text] [Related]
51. Max Perutz, a Nobel Prize winner, and Alain Marengo Rowe. Williams P Proc (Bayl Univ Med Cent); 2005 Apr; 18(2):138-40. PubMed ID: 16200163 [No Abstract] [Full Text] [Related]
52. Articles in memory of Alain Gautier. Biol Cell; 1996; 87(3):117-77. PubMed ID: 9102110 [No Abstract] [Full Text] [Related]
54. Standing on the Shoulders of the Giants: Dr. Alain Fischer. Mohty M; Fischer A Clin Hematol Int; 2023; 5(4):87882. PubMed ID: 37752988 [No Abstract] [Full Text] [Related]
56. Profile of John Clauser, Alain Aspect and Anton Zeilinger: 2022 Nobel laureates in Physics. Brassard G Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2304809120. PubMed ID: 37252965 [No Abstract] [Full Text] [Related]